CareDx, Inc. (CDNA): Revenue
$379.81M
Year ended 2025-12-31
$458.09M
Trailing 12 months to 2026-06-30
+5.7%
3-year compound annual growth
+14.6%
5-year compound annual growth
+29.7%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $379.81M | +13.8% | 2026-02-25, From 2025-01-01 |
| 2024-12-31 | $333.79M | +19.1% | 2026-02-25, From 2024-01-01 |
| 2023-12-31 | $280.32M | -12.9% | 2026-02-25, From 2023-01-01 |
| 2022-12-31 | $321.79M | +8.6% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $296.40M | +54.2% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $192.19M | +51.3% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $127.07M | +66.0% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $76.57M | +58.4% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $48.32M | +18.9% | 2020-02-28, From 2017-01-01 |
| 2016-12-31 | $40.63M | +44.4% | 2019-03-06, From 2016-01-01 |
| 2015-12-31 | $28.14M | +3.1% | 2018-03-22, From 2015-01-01 |
| 2014-12-31 | $27.31M | +23.6% | 2017-04-21, From 2014-01-01 |
| 2013-12-31 | $22.10M | +8.1% | 2016-03-29, From 2013-01-01 |
| 2012-12-31 | $20.45M | n/a | 2015-03-31, From 2012-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| CareDx, Inc. (CDNA) | 2025-12-31 | $379.81M | +13.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $344.23M | +3.7% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $322.67M | +13.8% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $305.11M | +100.0% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $517.14M | +16.0% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $812.03M | +97.0% |
| GRAIL, Inc. (GRAL) | 2025-12-31 | $147.17M | +17.2% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $982.02M | +32.9% |
| Biodesix Inc (BDSX) | 2025-12-31 | $88.50M | +24.1% |
Compare CDNA, CSTL, FLGT, BLLN side by side · Screen every company in Services-Medical Laboratories ↗